Epygenix Therapeutics - Ownership and Business Overview

Life ScienceCompany

Epygenix Therapeutics Ownership

Who owns Epygenix Therapeutics?

Epygenix Therapeutics is owned by Harmony Biosciences. It was acquired on April 30, 2024.

Epygenix Therapeutics Business Overview

Where is Epygenix Therapeutics headquartered?

Epygenix Therapeutics is headquartered in Paramus, New Jersey.

What sector is Epygenix Therapeutics in?

Epygenix Therapeutics is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 163 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 149 by strategics.

Epygenix Therapeutics

Epygenix Therapeutics, Inc.

140 E Ridgewood Ave.,
Paramus, New Jersey 07652
United States,
(201) 940-7377
www.epygenix.com

Epygenix Therapeutics is a precision medicine-based biopharmaceutical company focused on genetically screening, discovering, and developing drugs to treat rare and intractable forms of genetic epilepsy in childhood, such as Dravet syndrome (DS). Epygenix Therapeutics is based in Paramus, New Jersey.


 Subscribe to unlock this and 206,577
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.